| Target Price | $55.08 |
| Price | $45.38 |
| Potential | 21.38% |
| Number of Estimates | 22 |
| 22 Analysts have issued a price target Baker Hughes 2026 . The average Baker Hughes target price is $55.08. This is 21.38% higher than the current stock price. The highest price target is $64.05 41.14% , the lowest is $40.40 10.97% . | |
| A rating was issued by 26 analysts: 21 Analysts recommend Baker Hughes to buy, 4 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Baker Hughes stock has an average upside potential 2026 of 21.38% . Most analysts recommend the Baker Hughes stock at Purchase. |
25 Analysts have issued a sales forecast Baker Hughes 2025 . The average Baker Hughes sales estimate is $27.7b . This is 0.09% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $29.0b 4.48% , the lowest is $26.6b 3.91% .
This results in the following potential growth metrics:
| 2024 | $27.8b | 9.11% |
|---|---|---|
| 2025 | $27.7b | 0.52% |
| 2026 | $28.5b | 2.99% |
| 2027 | $30.1b | 5.49% |
| 2028 | $31.0b | 3.22% |
| 2029 | $33.3b | 7.25% |
25 Analysts have issued an Baker Hughes EBITDA forecast 2025. The average Baker Hughes EBITDA estimate is $4.8b . This is 0.95% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.2b 10.17% , the lowest is $4.6b 3.76% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $4.6b | 22.04% |
|---|---|---|
| 2025 | $4.8b | 4.62% |
| 2026 | $5.1b | 7.00% |
| 2027 | $5.7b | 11.48% |
| 2028 | $6.1b | 5.93% |
| 2029 | $6.6b | 8.86% |
| 2024 | 16.50% | 11.85% |
|---|---|---|
| 2025 | 17.35% | 5.17% |
| 2026 | 18.02% | 3.86% |
| 2027 | 19.05% | 5.72% |
| 2028 | 19.55% | 2.62% |
| 2029 | 19.84% | 1.48% |
26 Baker Hughes Analysts have issued a net profit forecast 2025. The average Baker Hughes net profit estimate is $2.5b . This is 13.87% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.7b 8.32% , the lowest is $2.3b 18.78% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $3.0b | 53.32% |
|---|---|---|
| 2025 | $2.5b | 16.42% |
| 2026 | $2.6b | 6.14% |
| 2027 | $3.0b | 13.48% |
| 2028 | $3.5b | 15.22% |
| 2029 | $3.8b | 10.95% |
| 2024 | 10.70% | 40.52% |
|---|---|---|
| 2025 | 8.99% | 16.02% |
| 2026 | 9.27% | 3.11% |
| 2027 | 9.97% | 7.55% |
| 2028 | 11.13% | 11.63% |
| 2029 | 11.51% | 3.41% |
26 Analysts have issued a Baker Hughes forecast for earnings per share. The average Baker Hughes EPS is $2.53 . This is 12.76% lower than earnings per share in the financial year 2024. The highest EPS forecast is $2.69 7.24% , the lowest is $2.38 17.93% .
This results in the following potential growth metrics and future valuations:
| 2024 | $2.98 | 56.02% |
|---|---|---|
| 2025 | $2.53 | 15.10% |
| 2026 | $2.68 | 5.93% |
| 2027 | $3.04 | 13.43% |
| 2028 | $3.50 | 15.13% |
| 2029 | $3.89 | 11.14% |
| Current | 15.65 | 14.47% |
|---|---|---|
| 2025 | 17.97 | 14.84% |
| 2026 | 16.93 | 5.79% |
| 2027 | 14.92 | 11.87% |
| 2028 | 12.95 | 13.20% |
| 2029 | 11.67 | 9.88% |
Based on analysts' sales estimates for 2025, the Baker Hughes stock is valued at an EV/Sales of 1.69 and an P/S ratio of 1.62 .
This results in the following potential growth metrics and future valuations:
| Current | 1.69 | 5.63% |
|---|---|---|
| 2025 | 1.69 | 0.12% |
| 2026 | 1.64 | 2.91% |
| 2027 | 1.56 | 5.20% |
| 2028 | 1.51 | 3.12% |
| 2029 | 1.41 | 6.76% |
| Current | 1.62 | 9.27% |
|---|---|---|
| 2025 | 1.62 | 0.09% |
| 2026 | 1.57 | 2.91% |
| 2027 | 1.49 | 5.21% |
| 2028 | 1.44 | 3.12% |
| 2029 | 1.34 | 6.76% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Neutral
➜
Neutral
|
Unchanged | Dec 12 2025 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Dec 11 2025 |
| Jefferies |
Buy
➜
Buy
|
Unchanged | Nov 20 2025 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Oct 28 2025 |
| Stifel |
Buy
➜
Buy
|
Unchanged | Oct 27 2025 |
| TD Cowen |
Buy
➜
Buy
|
Unchanged | Oct 27 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Oct 27 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Dec 12 2025 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Dec 11 2025 |
|
Unchanged
Jefferies:
Buy
➜
Buy
|
Nov 20 2025 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Oct 28 2025 |
|
Unchanged
Stifel:
Buy
➜
Buy
|
Oct 27 2025 |
|
Unchanged
TD Cowen:
Buy
➜
Buy
|
Oct 27 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Oct 27 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


